INM InMed Pharmaceuticals Inc. Common Shares PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

INM Stock Analysis: Buy, Sell, or Hold?

$15.56
+2.35 (+17.79%) ▲
5d: +872.5% 30d: +1069.92% 90d: +1003.55%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
35/100
Position
EXTENDED
30-Day Fair Range
$-1.08 – $6.24
Position: EXTENDED
Wall Street Target
$20.00
+28.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.41 / $16.44
Trend: Sideways
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: INM is 149.4% above its trading range ($6.24). While momentum could continue, risk/reward favors waiting for a pullback.

Get Alerted When INM Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: INM is currently trading at $15.56, which is considered extended relative to its 30-day fair value range of $-1.08 to $6.24.

Technical Outlook: Technically, INM is showing sideways momentum. Immediate support is located at $1.41, while resistance sits at $16.44. The stock is showing strong short-term momentum, up 17.8% recently.

Market Sentiment: INM scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+28.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $-1.08 - $6.24
Company Quality Score 35/100 (SELL)
Volume Confirmation HIGH
Confidence Score 21.1%

Trading Range & Key Levels

30-Day Trading Range $-1.08 - $6.24
Current vs Trading Range EXTENDED
Support Level $1.41
Resistance Level $16.44
Current Trend Sideways
Technical data as of Nov 6, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Technical Setup Structure MONITORING
Absorption: Inactive (CMF 0.17)
Pullback / Drawdown: -0.0% from 52W High
Consolidation: Trending (ADX 49.7)
30D Insider Cluster Signal CLUSTER BUY
30D Insider Buyers: 2 insiders ($33,401)
30D Net Insider Flow: +$33,401

Quantitative Signal Breakdown

  • BEARISH: Price significantly overextended (+149.4% above its trading range)
  • BEARISH: Weak technical setup (15/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+17.8%)
  • BULLISH: Trading 28.5% below Wall St target ($20.00)
  • WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Wall Street Target $20.00 (+28.5%)
Revenue Growth (YoY) -26.2%
Share INM Analysis

Share this live INM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (INM)

Bearish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 7, 2026
Daily AI digest
AI Retail Discussion Summary: InMed Pharmaceuticals has completed its merger with Mentari Therapeutics and announced the trading of its shares on Nasdaq under the ticker symbol 'MTRI' starting November 9, 2026. The company raised approximately $490 million in gross proceeds during the merger.
Key Retail Themes: Merger completion and trading on Nasdaq Fundraising and proceeds from the merger
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 8:32 PM ET
Data refreshes hourly during market hours. Next update: 9:32 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for INM.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
28 analysts
$208 30 SELL
ALKS
Alkermes Plc
STRONG BUY
20 analysts
$58 39 SELL
TEVA
Teva Pharma Industries L…
STRONG BUY
15 analysts
$49 47 HOLD
AMLX
Amylyx Pharmaceuticals I…
STRONG BUY
12 analysts
$43 55 HOLD
AQST
Aquestive Therapeutics I…
STRONG BUY
9 analysts
$9 59 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive INM Research Pages
INM Technical Chart INM Price Prediction INM Intrinsic Value DCF INM Earnings Date INM Investment Advisor INM Fair Price Analyzer INM Target Price Playground INM LEAP Simulator INM Supply Chain Tear-Down INM Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals